We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agennix Announces Issuance of European Patent Covering Use of Talactoferrin to Treat Cancer

News   Aug 12, 2011

 
Agennix Announces Issuance of European Patent Covering Use of Talactoferrin to Treat Cancer
 
 
 

RELATED ARTICLES

Putting Concussion Under the Genetic Microscope

News

The world’s first study on whether genetic variations are involved in the post-traumatic headache experienced by some people following concussion is underway at QUT, funded by a $250,000 US Department of Defence grant.

READ MORE

New DNA-nanotechnology Enhances DNA and RNA Analysis

News

A research team has now developed "Signal Amplification by Exchange Reaction" (SABER), a highly programmable and practical method that significantly enhances the sensitivity as well as customization and multiplexing capabilities of Fluorescence in situ hybridization analysis.

READ MORE

Women With Sleep Apnea More Likely to Be Diagnosed With Cancer Than Men

News

A recent study shows that women with obstructive sleep apnea (OSA) are more likely to be diagnosed with cancer than men with the condition

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE